Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Résultat de la recherche
2 recherche sur le mot-clé 'Clozapine'
Affiner la recherche Générer le flux rss de la recherche
Partager le résultat de cette recherche Faire une suggestion
Case Report: Successful Use of the Combination of Electroconvulsive Therapy and Clozapine in Treating Treatment-Resistant Schizophrenia and Catatonia in an Adult with Intellectual Disability / P. DESARKAR in Journal of Autism and Developmental Disorders, 48-10 (October 2018)
[article]
Titre : Case Report: Successful Use of the Combination of Electroconvulsive Therapy and Clozapine in Treating Treatment-Resistant Schizophrenia and Catatonia in an Adult with Intellectual Disability Type de document : Texte imprimé et/ou numérique Auteurs : P. DESARKAR, Auteur ; D. BLUMBERGER, Auteur ; Z. J. DASKALAKIS, Auteur Article en page(s) : p.3637-3640 Langues : Anglais (eng) Mots-clés : Catatonia Clozapine Electroconvulsive therapy Intellectual disability Treatment-resistant schizophrenia Index. décimale : PER Périodiques Résumé : There is paucity of empirical data regarding the use of either clozapine or electroconvulsive therapy (ECT) in the acute phase and maintenance treatment of schizophrenia in adults with intellectual disability. Herein we report the successful acute and long-term remission of psychotic symptoms and catatonia with the combination of clozapine and ECT in a 26-year-old female with moderate ID and treatment-resistant schizophrenia. To our knowledge, this is the first case example of the successful use of the combination of bilateral, standard-pulse ECT and clozapine in both acute and long-term treatment of treatment-resistant schizophrenia and catatonia in an adult with ID. Our report adds further support to the emerging evidence regarding the efficacy and safety of this combination in treatment-resistant schizophrenia. En ligne : http://dx.doi.org/10.1007/s10803-018-3589-7 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=369
in Journal of Autism and Developmental Disorders > 48-10 (October 2018) . - p.3637-3640[article] Case Report: Successful Use of the Combination of Electroconvulsive Therapy and Clozapine in Treating Treatment-Resistant Schizophrenia and Catatonia in an Adult with Intellectual Disability [Texte imprimé et/ou numérique] / P. DESARKAR, Auteur ; D. BLUMBERGER, Auteur ; Z. J. DASKALAKIS, Auteur . - p.3637-3640.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 48-10 (October 2018) . - p.3637-3640
Mots-clés : Catatonia Clozapine Electroconvulsive therapy Intellectual disability Treatment-resistant schizophrenia Index. décimale : PER Périodiques Résumé : There is paucity of empirical data regarding the use of either clozapine or electroconvulsive therapy (ECT) in the acute phase and maintenance treatment of schizophrenia in adults with intellectual disability. Herein we report the successful acute and long-term remission of psychotic symptoms and catatonia with the combination of clozapine and ECT in a 26-year-old female with moderate ID and treatment-resistant schizophrenia. To our knowledge, this is the first case example of the successful use of the combination of bilateral, standard-pulse ECT and clozapine in both acute and long-term treatment of treatment-resistant schizophrenia and catatonia in an adult with ID. Our report adds further support to the emerging evidence regarding the efficacy and safety of this combination in treatment-resistant schizophrenia. En ligne : http://dx.doi.org/10.1007/s10803-018-3589-7 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=369 Case Reports: Clozapine for the Treatment of Catatonia in Autism Spectrum Disorder / Robyn P. THOM in Journal of Autism and Developmental Disorders, 52-6 (June 2022)
[article]
Titre : Case Reports: Clozapine for the Treatment of Catatonia in Autism Spectrum Disorder Type de document : Texte imprimé et/ou numérique Auteurs : Robyn P. THOM, Auteur ; Christopher J. MCDOUGLE, Auteur Article en page(s) : p.2855-2858 Langues : Anglais (eng) Mots-clés : Autism spectrum disorder Catatonia Clozapine Index. décimale : PER Périodiques Résumé : Catatonia is a severe clinical syndrome which has been increasingly reported in autism spectrum disorder (ASD). The prevalence of catatonia in ASD is unknown. Diagnosing catatonia in ASD is complicated by overlapping clinical features such as mutism, stereotypies, and echophenomena. Here, we present the clinical histories of two individuals with ASD and catatonia who were successfully treated with clozapine. We have reported on a novel potential treatment option for catatonia in ASD. Additional studies are needed to evaluate the safety, efficacy, and tolerability of clozapine for the treatment of catatonia in ASD. En ligne : http://dx.doi.org/10.1007/s10803-021-05149-8 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=475
in Journal of Autism and Developmental Disorders > 52-6 (June 2022) . - p.2855-2858[article] Case Reports: Clozapine for the Treatment of Catatonia in Autism Spectrum Disorder [Texte imprimé et/ou numérique] / Robyn P. THOM, Auteur ; Christopher J. MCDOUGLE, Auteur . - p.2855-2858.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 52-6 (June 2022) . - p.2855-2858
Mots-clés : Autism spectrum disorder Catatonia Clozapine Index. décimale : PER Périodiques Résumé : Catatonia is a severe clinical syndrome which has been increasingly reported in autism spectrum disorder (ASD). The prevalence of catatonia in ASD is unknown. Diagnosing catatonia in ASD is complicated by overlapping clinical features such as mutism, stereotypies, and echophenomena. Here, we present the clinical histories of two individuals with ASD and catatonia who were successfully treated with clozapine. We have reported on a novel potential treatment option for catatonia in ASD. Additional studies are needed to evaluate the safety, efficacy, and tolerability of clozapine for the treatment of catatonia in ASD. En ligne : http://dx.doi.org/10.1007/s10803-021-05149-8 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=475